Toumaz Technology Limited, the leading provider of ultra-low power wireless infrastructure for body monitoring solutions, today announces that Toumaz Co-Founder, Chairman and Chief Technology Officer Professor Chris Toumazou has been elected as a Fellow of the Royal Society – the highest honour in the UK scientific system. The Royal Society is the national academy of science for the UK and Commonwealth and is the world’s oldest scientific academy in continuous existence. The Royal Society counts the world’s most eminent scientists among its Fellowship and Foreign Membership, which has included Isaac Newton, Charles Darwin, Albert Einstein and Stephen Hawking.
Professor Toumazou, a world expert in the field of low power analogue circuit design, current mode circuits and systems for radio frequency and biomedical applications, has been distinguished following a peer review process for his major advances in low-power analogue signal processing. The Royal Society, which will celebrate its 350th anniversary in 2010, counts more than 60 Nobel Laureates amongst its approximately 1400 Fellows and Foreign Members. The honour of Fellowship to the Royal Society follows Professor Toumazou’s 2007 award of a Silver Medal from the Royal Academy of Engineering.
Commenting on his election to Fellow of the Royal Society, Professor Toumazou said, “Being elected a Fellow of the Royal Society is such a privilege and I feel honoured that my hard work and passion for my science has been endorsed in this way.”
Professor Toumazou FRS co-founded Toumaz Technology in 2000 to exploit developments in ultra-low power silicon chip technology at Imperial College London. The patented core technology, Advanced Mixed Signal Processing (AMx™), is the basis for Toumaz’s Sensium™ technology platform for intelligent wireless body monitoring.
Professor Toumazou currently holds the Winston Wong Chair in Biomedical Circuits at Imperial College London and is Director and Chief Scientist of the new Institute of Biomedical Engineering at Imperial. In recognition of his outstanding research, he was made a Professor at Imperial at the age of 33 – one of the youngest ever. He holds 23 patents, many of which are now fully granted in key territories throughout the world, and has published over 320 research papers in the field of RF and low power electronics.
Through his extensive record, Professor Toumazou has invented innovative electronic devices ranging from dual-mode cellular phones to ultra-low power devices for medical diagnosis and therapy. His pioneering research has demonstrated how the natural analogue physics of silicon semiconductor technology can be used to replace and monitor biological functions, resulting in – among other achievements – the development of one of the world's first totally implantable cochlear prosthetics. Current breakthrough research includes the development of an artificial retina and pancreas in silicon using nanowatts of power.
Professor Toumazou led a major campaign to raise £22 million to fund the creation of the Institute of Biomedical Engineering at Imperial College, which opened its state-of-the-art, purpose-built facilities in 2006. By combining the strengths of Imperial’s world class research schools in engineering and medicine, the IBE draws together scientists, medical researchers, clinicians and engineers to drive major advances in key areas of medical diagnosis and treatment, including personalised healthcare, regenerative medicine and biomedical imaging. As founding Director and head of research in Bionics, Professor Toumazou’s aim is to create an international centre of excellence in biomedical engineering research – generating high quality intellectual property, and accelerating the commercial realisation of technologies to improve the lives of people around the world.
About Toumaz Technology
Toumaz Technology Limited is the leading provider of ultra-low power wireless infrastructure for body monitoring solutions.
Toumaz’s ultra low-power smart sensor interface and transceiver platform – the Sensium™ – enables non-intrusive, real-time wireless monitoring of multiple vital signs for a wide range of healthcare and lifestyle management applications. Based on Toumaz’s patented ultra-low power Advanced Mixed Signal (AMx)™ technology, the Sensium provides the enabling technology to connect the mobile individual to healthcare providers – simply, affordably and unobtrusively.
For healthcare professionals, this transforms the possibilities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible, personalised healthcare, as well as better therapeutic outcomes.
About the Royal Society
The Royal Society is the world's oldest scientific academy in continuous existence, and has been at the forefront of enquiry and discovery since its foundation in 1660.
The backbone of the Society is its Fellowship of the most eminent scientists of the day, elected by peer review for life and entitled to use FRS after their name. There are currently more than 60 Nobel Laureates amongst the Society's approximately 1400 Fellows and Foreign Members.
Throughout its history, the Society has promoted excellence in science through its Fellowship and Foreign Membership, which has included Isaac Newton, Charles Darwin, Ernest Rutherford, Albert Einstein, Dorothy Hodgkin, Francis Crick, James Watson and Stephen Hawking.
P: +44 870 285 1650